Login / Signup
Frederik C Gulmark Hansen
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 5
Top Topics
Phase Iii
Squamous Cell Carcinoma
Clinical Trial
Study Protocol
Top Venues
Journal of breast cancer
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Frederik C Gulmark Hansen
,
Mads Gustaf Jørgensen
,
Jens Ahm Sørensen
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial.
Journal of breast cancer
(2023)
Frederik C Gulmark Hansen
,
Mads Gustaf Jørgensen
,
Jens Ahm Sørensen
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial.
Journal of breast cancer
26 (1) (2023)
Frederik C Gulmark Hansen
,
Mads Gustaf Jørgensen
,
Jens Ahm Sørensen
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial.
Journal of breast cancer
26 (1) (2023)
Frederik C Gulmark Hansen
,
Mads Gustaf Jørgensen
,
Jens Ahm Sørensen
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial.
Journal of breast cancer
26 (1) (2023)
Frederik C Gulmark Hansen
,
Mads Gustaf Jørgensen
,
Jens Ahm Sørensen
Treatment of Breast Cancer-Related Lymphedema With Topical Tacrolimus: A Prospective, Open-Label, Single-Arm, Phase II Pilot Trial.
Journal of breast cancer
26 (1) (2023)